Pachychoroid-phenotype effects on 5-year visual outcomes of anti-VEGF monotherapy in polypoidal choroidal vasculopathy.

Yuichiro ShimizuManabu MiyataSotaro OotoMasahiro MiyakeYuki MoriHiroshi TamuraNaoko Ueda-ArakawaAkihito UjiYuki MuraokaAyako TakahashiTomotaka WakazonoKenji YamashiroMasayuki HataAkitaka Tsujikawa

Published in: Acta ophthalmologica (2021)

Our findings suggest that anti-VEGF monotherapy was similarly effective for pachychoroid- and non-pachychoroid-phenotype eyes with PCV, for at least 5 years, although further studies are required.

Keyphrases

optical coherence tomography
vascular endothelial growth factor
endothelial cells
combination therapy
open label
age related macular degeneration
type diabetes
case control
skeletal muscle
adipose tissue
study protocol
cataract surgery
double blind